Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICHOR HOLDINGS, LTD.ICHR · Entity 4529 | Director | May 15, 2024 | May 17, 2024 |
| LAM RESEARCH CORPLRCX · Entity 1467 | Chief Legal Officer & SVP | December 19, 2019 | December 23, 2019 |
| Protagonist Therapeutics, IncPTGX · Entity 3552 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICHOR HOLDINGS, LTD.
Report date May 15, 2024 · Filed May 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value $0.0001SEC Table I · non-derivative | Direct | 28,325 |
Reported balance
After 2024-05-15 transaction · row 1
1 source rowRow 1 · 2024-05-15 · Grant · Acquired 3,923 · Balance 28,325 F1: Consists of an RSU grant, representing the right to receive Ordinary Shares of Ichor Holdings, Ltd. The RSU vests in full on May 9, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an RSU grant, representing the right to receive Ordinary Shares of Ichor Holdings, Ltd. The RSU vests in full on May 9, 2025.
LAM RESEARCH CORP
Report date December 19, 2019 · Filed December 23, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,084 |
Reported balance
After 2019-12-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-12-19 · Sale · Disposed 3,831 · Balance 32,084 F1: The reporting person contributed LRCX common stock to an exchange fund in exchange for shares of the exchange fund. The LRCX common stock was valued at $287.804 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person. F2: Amount reported includes shares subject to unvested Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person contributed LRCX common stock to an exchange fund in exchange for shares of the exchange fund. The LRCX common stock was valued at $287.804 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.
F2: Amount reported includes shares subject to unvested Restricted Stock Units.
Protagonist Therapeutics, Inc
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,825 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 2,695 · Balance 7,825 F1: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $87.18 · Expires 2036-01-02 | Direct | 3,762 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Grant · Acquired 3,762 · Balance 3,762 F2: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date.
F2: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2017 Filed Feb 23, 2017 01:13 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 18,835 | $114.90 | $2,164,141.50 |
DisclosureSEC source: 0000707549-17-000025 · wf-form4_148781241979038.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 12,557 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/17. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. The performance payout was approved at 150% of target. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 17, 2017 Filed Feb 23, 2017 01:13 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 1,258 | $114.90 | $144,544.20 |
DisclosureSEC source: 0000707549-17-000025 · wf-form4_148781241979038.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,549 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 18:25 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 841 | $115.99 | $97,547.59 |
DisclosureSEC source: 0000707549-17-000012 · wf-form4_148709670767079.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,807 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 23:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 3,347 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-16-000116 · wf-form4_148098092669178.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,648 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2016 Filed Mar 3, 2016 20:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 10,127 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-16-012222 · wf-form4_145703614942226.xml · derivative · entry 3 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,748 Underlying: Common Stock · 10,127 shares Expires not disclosed F4 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/19. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/1/16 to 2/1/19). F4 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/19. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/1/16 to 2/1/19). Read SEC document |
| March 01, 2016 Filed Mar 3, 2016 20:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,150 | $0.00 Strike: $75.57 | $0.00 |
DisclosureSEC source: 0001628280-16-012222 · wf-form4_145703614942226.xml · derivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,424 Underlying: Common Stock · 12,150 shares Expires 2023-03-01 F3 · derivative.exercise_date: 33.3% of the stock options will vest on 3/1/17, 3/1/18, and 3/1/19. Read SEC document |
| March 01, 2016 Filed Mar 3, 2016 20:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 6,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-16-012222 · wf-form4_145703614942226.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,636 F1 · shares: 33.3% of the RSUs will vest on 3/1/17, 3/1/18, and 3/1/19. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 22, 2016 Filed Feb 22, 2016 23:30 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 8,918 | $67.77 | $604,372.86 |
DisclosureSEC source: 0001628280-16-011509 · wf-form4_145618382910465.xml · nonDerivative · entry 3 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 6,278 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/16. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. The performance payout was approved at 142.06% of target. The award vested on 2/18/16 and the shares were distributed on 2/22/16. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 01:03 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 4,018 | $67.77 | $272,299.86 |
DisclosureSEC source: 0001628280-16-011618 · wf-form4_145627578076775.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,560 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 23:30 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionMarket-based Performance Restricted Stock Unit · Derivative | 6,278 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-16-011509 · wf-form4_145618382910465.xml · derivative · entry 4 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,621 Underlying: Common Stock · 6,278 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 6,278 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/16. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. The performance payout was approved at 142.06% of target. The award vested on 2/18/16 and the shares were distributed on 2/22/16. F3 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/18/14 to 2/17/16). F3 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/18/14 to 2/17/16). Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 23:30 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 1,258 | $67.77 | $85,254.66 |
DisclosureSEC source: 0001628280-16-011509 · wf-form4_145618382910465.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,660 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 23:30 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 1,887 | $67.77 | $127,881.99 |
DisclosureSEC source: 0001628280-16-011509 · wf-form4_145618382910465.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,918 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 11, 2016 Filed Feb 17, 2016 00:37 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 862 | $64.21 | $55,349.02 |
DisclosureSEC source: 0001628280-16-011279 · wf-form4_145566941225425.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,805 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 22:34 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,000 | $70.59 | $352,950.00 |
DisclosureSEC source: 0001192381-15-000024 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,318 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 19:03 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 1,258 | $81.92 | $103,055.36 |
DisclosureSEC source: 0001192381-15-000017 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,318 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2015 Filed Feb 24, 2015 00:38 UTC Amendment | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 1,258 | $81.92 | $103,055.36 |
DisclosureSEC source: 0001192381-15-000023 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,318 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 11, 2015 Filed Feb 14, 2015 00:47 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 8,064 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001192381-15-000014 · primary_doc.xml · derivative · entry 3 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,899 Underlying: Common Stock · 8,064 shares Expires not disclosed F4 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/2/18. F4 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/2/18. Read SEC document |
| February 11, 2015 Filed Feb 14, 2015 00:47 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,836 | $0.00 Strike: $80.60 | $0.00 |
DisclosureSEC source: 0001192381-15-000014 · primary_doc.xml · derivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,274 Underlying: Common Stock · 4,836 shares Expires 2022-02-11 F3 · derivative.exercise_date: 33.3% of the stock options will vest on 2/11/16, 2/11/17, and 2/11/18. Read SEC document |
| February 11, 2015 Filed Feb 14, 2015 00:47 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 6,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-15-000014 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,576 F1 · shares: 33.3% of the RSUs will vest on 2/11/16, 2/11/17, 2/11/18. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 10, 2015 Filed Feb 12, 2015 01:51 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,000 | $79.51 | $397,570.00 |
DisclosureSEC source: 0001192381-15-000007 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,125 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.50 - $79.54, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 06, 2015 Filed Feb 10, 2015 22:08 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 2,817 | $78.14 | $220,120.38 |
DisclosureSEC source: 0001192381-15-000004 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,125 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2014 Filed Feb 21, 2014 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 6,278 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000012 · primary_doc.xml · derivative · entry 6 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,835 Underlying: Common Stock · 6,278 shares Expires not disclosed F7 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. F7 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. Read SEC document |
| February 18, 2014 Filed Feb 21, 2014 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 12,557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000012 · primary_doc.xml · derivative · entry 5 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,557 Underlying: Common Stock · 12,557 shares Expires not disclosed F6 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/17. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. F6 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/17. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. Read SEC document |
| February 18, 2014 Filed Feb 21, 2014 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,765 | $0.00 Strike: $51.76 | $0.00 |
DisclosureSEC source: 0001192381-14-000012 · primary_doc.xml · derivative · entry 4 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,438 Underlying: Common Stock · 3,765 shares Expires 2021-02-18 F5 · derivative.exercise_date: 100% of the stock options will vest on 2/18/16. Read SEC document |
| February 18, 2014 Filed Feb 21, 2014 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 7,533 | $0.00 Strike: $51.76 | $0.00 |
DisclosureSEC source: 0001192381-14-000012 · primary_doc.xml · derivative · entry 3 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,673 Underlying: Common Stock · 7,533 shares Expires 2021-02-18 F4 · derivative.exercise_date: 33.3% of the stock options will vest on 2/18/15, 2/18/16 and 2/18/17. Read SEC document |
| February 18, 2014 Filed Feb 21, 2014 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 5,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000012 · primary_doc.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,409 F2 · shares: 100% of the RSUs will vest on 2/18/16. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2014 Filed Feb 21, 2014 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 10,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000012 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,386 F1 · shares: 33.3% of the RSUs will vest on 2/18/15, 2/18/16 and 2/18/17. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 07, 2014 Filed Feb 11, 2014 21:27 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,481 | $51.85 | $284,189.85 |
DisclosureSEC source: 0001192381-14-000005 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,340 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 21, 2013 Filed Oct 23, 2013 18:43 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 6,000 | $54.36 | $326,160.00 |
DisclosureSEC source: 0001192381-13-000010 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,821 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| September 24, 2013 Filed Sep 26, 2013 18:20 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,000 | $51.52 | $257,620.00 |
DisclosureSEC source: 0001192381-13-000004 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,821 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:58 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 3,000 | $47.75 | $143,250.00 |
DisclosureSEC source: 0001501289-13-000037 · primary_doc.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,821 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| September 03, 2013 Filed Sep 5, 2013 20:58 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 2,000 | $47.77 | $95,540.00 |
DisclosureSEC source: 0001501289-13-000037 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. Read SEC document |
| August 06, 2013 Filed Aug 8, 2013 22:52 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionStock Option (right to buy) · Derivative | 38,658 | $20.21 Strike: $20.21 | $781,278.18 |
DisclosureSEC source: 0001501289-13-000035 · primary_doc.xml · derivative · entry 4 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,140 Underlying: Common Stock · 38,658 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2013 Filed Aug 8, 2013 22:52 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,410 | $48.73 | $263,618.48 |
DisclosureSEC source: 0001501289-13-000035 · primary_doc.xml · nonDerivative · entry 3 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,454 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.71 - $48.74, inclusive. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| August 06, 2013 Filed Aug 8, 2013 22:52 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 27,838 | $48.74 | $1,356,824.12 |
DisclosureSEC source: 0001501289-13-000035 · primary_doc.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 06, 2013 Filed Aug 8, 2013 22:52 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 38,658 | $20.21 | $781,278.18 |
DisclosureSEC source: 0001501289-13-000035 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2013 Filed Mar 7, 2013 00:22 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 2,797 | $42.59 | $119,124.23 |
DisclosureSEC source: 0001501289-13-000020 · primary_doc.xml · nonDerivative · entry 3 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,668 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| March 04, 2013 Filed Mar 7, 2013 00:22 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 2,025 | $42.59 | $86,244.75 |
DisclosureSEC source: 0001501289-13-000020 · primary_doc.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 04, 2013 Filed Mar 7, 2013 00:22 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerCommon Stock | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001501289-13-000020 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 08, 2013 Filed Feb 12, 2013 23:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantStock Option (right to buy) · Derivative | 22,140 | $42.61 Strike: $42.61 | $943,385.40 |
DisclosureSEC source: 0001501289-13-000015 · primary_doc.xml · derivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,798 Underlying: Common Stock · 22,140 shares Expires 2020-02-08 F1 · derivative.exercise_date: 100% of the option will vest and become exercisable on 02/08/15. Read SEC document |
| February 08, 2013 Filed Feb 12, 2013 23:15 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 7,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001501289-13-000015 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,898 F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 07, 2012 Filed Feb 10, 2012 01:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 14,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001501289-12-000018 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,835 Read SEC document |
| February 06, 2012 Filed Feb 8, 2012 22:55 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 3,443 | $43.23 | $148,840.89 |
DisclosureSEC source: 0001501289-12-000014 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,428 Read SEC document |
| February 05, 2012 Filed Feb 7, 2012 22:33 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 3,535 | $44.19 | $156,211.65 |
DisclosureSEC source: 0001501289-12-000013 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,871 Read SEC document |
| March 08, 2011 Filed Mar 8, 2011 23:36 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 176 | $0.00 | $0.00 |
DisclosureSEC source: 0001447149-11-000003 · primary_doc.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,727 Read SEC document |
| March 08, 2011 Filed Mar 9, 2011 22:16 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 1,000 | $58.01 | $58,010.00 |
DisclosureSEC source: 0001447149-11-000004 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,727 Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 23:36 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 10,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001447149-11-000003 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 02, 2011 Filed Mar 4, 2011 19:55 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,000 | $57.35 | $286,755.00 |
DisclosureSEC source: 0001447149-11-000002 · primary_doc.xml · nonDerivative · entry 2 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,179 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.34 - $57.40, inclusive. Read SEC document |
| February 28, 2011 Filed Mar 4, 2011 19:55 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001447149-11-000002 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 25, 2011 Filed Mar 1, 2011 19:19 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,671 | $55.35 | $313,889.85 |
DisclosureSEC source: 0001447149-11-000001 · primary_doc.xml · nonDerivative · entry 1 O'Dowd Sarah A · CIK 0001447149 · VP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,540 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.